Remedent Inc
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patien… Read more
Remedent Inc (REMI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2024: -0.038x
Based on the latest financial reports, Remedent Inc (REMI) has a cash flow conversion efficiency ratio of -0.038x as of March 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-92.50K) by net assets ($2.45 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Remedent Inc - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Remedent Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Remedent Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Remedent Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MAPT4F
SA:MAPT4F
|
N/A |
|
SADICO CAN THO
VN:SDG
|
N/A |
|
Pesquera Exalmar S.A.A.
LIM:EXALMC1
|
N/A |
|
Auryn Mining Corp
PINK:AUMC
|
N/A |
|
AUSGOLD
BE:AU4
|
N/A |
|
Groupe Airwell Société anonyme
PA:ALAIR
|
-0.126x |
|
1369 Construction JSC
VN:C69
|
N/A |
|
Time Finance PLC
LSE:TIME
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Remedent Inc (2002–2024)
The table below shows the annual cash flow conversion efficiency of Remedent Inc from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-03-31 | $2.45 Million | $-130.51K | -0.053x | -174.65% |
| 2023-03-31 | $2.73 Million | $-53.07K | -0.019x | +51.18% |
| 2022-03-31 | $4.25 Million | $-168.95K | -0.040x | -10327.84% |
| 2021-03-31 | $4.43 Million | $1.72K | 0.000x | -98.23% |
| 2020-03-31 | $4.62 Million | $101.55K | 0.022x | -78.85% |
| 2019-03-31 | $5.46 Million | $567.62K | 0.104x | +1592.89% |
| 2018-03-31 | $3.31 Million | $20.33K | 0.006x | -98.83% |
| 2017-03-31 | $3.18 Million | $1.67 Million | 0.525x | +686.93% |
| 2016-03-31 | $2.27 Million | $-203.11K | -0.089x | -162.61% |
| 2015-03-31 | $2.10 Million | $300.57K | 0.143x | +418.85% |
| 2014-03-31 | $2.32 Million | $-103.94K | -0.045x | +92.96% |
| 2013-03-31 | $1.49 Million | $-946.32K | -0.636x | -1004.59% |
| 2012-03-31 | $1.91 Million | $-109.78K | -0.058x | -29.21% |
| 2011-03-31 | $3.03 Million | $-135.23K | -0.045x | -175.18% |
| 2010-03-31 | $3.93 Million | $232.88K | 0.059x | +142.67% |
| 2009-03-31 | $6.33 Million | $-880.49K | -0.139x | +78.89% |
| 2008-03-31 | $3.71 Million | $-2.45 Million | -0.658x | +26.48% |
| 2007-03-31 | $736.09K | $-659.31K | -0.896x | +41.82% |
| 2006-03-31 | $1.96 Million | $-3.01 Million | -1.540x | -338.60% |
| 2005-03-31 | $904.68K | $583.73K | 0.645x | -81.47% |
| 2004-03-31 | $-154.05K | $-536.47K | 3.483x | +608.74% |
| 2003-03-31 | $-1.19 Million | $-582.75K | 0.491x | +45347.49% |
| 2002-03-31 | $-730.79 Million | $-790.11K | 0.001x | -- |